Immunogenicity, Effectiveness, and Safety of COVID-19 Vaccines in Rheumatic Patients: An Updated Systematic Review and Meta-Analysis
出版年份 2022 全文链接
标题
Immunogenicity, Effectiveness, and Safety of COVID-19 Vaccines in Rheumatic Patients: An Updated Systematic Review and Meta-Analysis
作者
关键词
-
出版物
Biomedicines
Volume 10, Issue 4, Pages 834
出版商
MDPI AG
发表日期
2022-04-02
DOI
10.3390/biomedicines10040834
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine
- (2021) Jerald Sadoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comorbidities in rheumatic diseases need special consideration during the COVID-19 pandemic
- (2021) Sakir Ahmed et al. RHEUMATOLOGY INTERNATIONAL
- Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19
- (2021) Kathryn E. Stephenson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Coronavirus disease 2019, immune-mediated inflammatory diseases and immunosuppressive therapies – A Danish population-based cohort study
- (2021) Mohamed Attauabi et al. JOURNAL OF AUTOIMMUNITY
- COVID-19 vaccination and antirheumatic therapy
- (2021) Jack Arnold et al. RHEUMATOLOGY
- Reduced humoral response to mRNA SARS‐CoV‐2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus
- (2021) Ayelet Grupper et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases
- (2021) Brian J Boyarsky et al. ANNALS OF THE RHEUMATIC DISEASES
- Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort
- (2021) Ulf M Geisen et al. ANNALS OF THE RHEUMATIC DISEASES
- BNT162b2 vaccination in heart transplant recipients: clinical experience and antibody response
- (2021) Yael Peled et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Risk factors for severe outcomes in patients with systemic vasculitis & COVID‐19: a bi‐national registry‐based cohort study
- (2021) Matthew A Rutherford et al. Arthritis & Rheumatology
- Effect of Immunosuppression on the Immunogenicity of mRNA Vaccines to SARS-CoV-2
- (2021) Parakkal Deepak et al. ANNALS OF INTERNAL MEDICINE
- Antibody response to the Janssen/Johnson & Johnson SARS-CoV-2 vaccine in patients with rheumatic and musculoskeletal diseases
- (2021) Teresa Po-Yu Chiang et al. ANNALS OF THE RHEUMATIC DISEASES
- LB0002 COVID-19 VACCINE SAFETY IN PATIENTS WITH RHEUMATIC AND MUSCULOSKELETAL DISEASE
- (2021) P. M. Machado et al. ANNALS OF THE RHEUMATIC DISEASES
- POS1255 REACTOGENICITY OF SARS-COV-2 VACCINES IN PATIENTS WITH AUTOIMMUNE AND INFLAMMATORY DISEASE
- (2021) M. Yang et al. ANNALS OF THE RHEUMATIC DISEASES
- Humoral and T-cell responses to SARS-CoV-2 vaccination in patients receiving immunosuppression
- (2021) Maria Prendecki et al. ANNALS OF THE RHEUMATIC DISEASES
- Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study
- (2021) Victoria Furer et al. ANNALS OF THE RHEUMATIC DISEASES
- Disease activity and humoral response in patients with inflammatory rheumatic diseases after two doses of the Pfizer mRNA vaccine against SARS-CoV-2
- (2021) Yolanda Braun-Moscovici et al. ANNALS OF THE RHEUMATIC DISEASES
- SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity
- (2021) Daniel Mrak et al. ANNALS OF THE RHEUMATIC DISEASES
- High antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with rheumatic and musculoskeletal diseases
- (2021) Jake A Ruddy et al. ANNALS OF THE RHEUMATIC DISEASES
- Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis
- (2021) Serena Bugatti et al. ANNALS OF THE RHEUMATIC DISEASES
- Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory disease
- (2021) Rebecca H Haberman et al. ANNALS OF THE RHEUMATIC DISEASES
- Evaluation of the safety profile of COVID-19 vaccines: a rapid review
- (2021) Qianhui Wu et al. BMC Medicine
- Assessment of humoral and cellular immunity induced by the BNT162b2 SARS-CoV-2 vaccine in healthcare workers, elderly people, and immunosuppressed patients with autoimmune disease
- (2021) Giacomo Malipiero et al. IMMUNOLOGIC RESEARCH
- Presence of specific T cell response after SARS-CoV-2 vaccination in rheumatoid arthritis patients receiving rituximab
- (2021) Maurizio Benucci et al. IMMUNOLOGIC RESEARCH
- SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study
- (2021) Maria Pia Sormani et al. Multiple Sclerosis Journal
- Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trial
- (2021) Ana C. Medeiros-Ribeiro et al. NATURE MEDICINE
- Antibody response to inactivated COVID-19 vaccine (CoronaVac) in immune-mediated diseases: a controlled study among hospital workers and elderly
- (2021) Emire Seyahi et al. RHEUMATOLOGY INTERNATIONAL
- Safety of the ChAdOx1 nCoV-19 and the BBV152 vaccines in 724 patients with rheumatic diseases: a post-vaccination cross-sectional survey
- (2021) Somy Cherian et al. RHEUMATOLOGY INTERNATIONAL
- Local and systemic reactogenicity of COVID-19 vaccine BNT162b2 in patients with systemic lupus erythematosus and rheumatoid arthritis
- (2021) Lars Erik Bartels et al. RHEUMATOLOGY INTERNATIONAL
- Disease Flare and Reactogenicity in Patients with Rheumatic and Musculoskeletal Diseases Following Two‐Dose SARS‐CoV‐2 Messenger RNA Vaccination
- (2021) Caoilfhionn M. Connolly et al. Arthritis & Rheumatology
- Evaluation of Immune Response and Disease Status in SLE Patients Following SARS‐CoV‐2 Vaccination
- (2021) Peter M. Izmirly et al. Arthritis & Rheumatology
- American College of Rheumatology Guidance for COVID‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 3
- (2021) Jeffrey R. Curtis et al. Arthritis & Rheumatology
- Safety and tolerability of the COVID‐19 mRNA‐vaccine in adolescents with juvenile idiopathic arthritis on treatment with TNF‐inhibitors
- (2021) Dimitra Dimopoulou et al. Arthritis & Rheumatology
- ImmunosuppressiveTherapies Differently Modulate Humoral- and T-Cell-Specific Responses to COVID-19 mRNA Vaccine in Rheumatoid Arthritis Patients
- (2021) Andrea Picchianti-Diamanti et al. Frontiers in Immunology
- Preliminary Data on Post Market Safety Profiles of COVID 19 Vaccines in Rheumatic Diseases: Assessments on Various Vaccines in Use, Different Rheumatic Disease Subtypes, and Immunosuppressive Therapies: A Two-Centers Study
- (2021) Cinzia Rotondo et al. Vaccines
- Vaccine response following anti-CD20 therapy: a systematic review and meta-analysis of 905 patients
- (2021) Abi Vijenthira et al. Blood Advances
- Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey
- (2021) Sebastian Eduardo Sattui et al. RMD Open
- Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands: a substudy of data from two prospective cohort studies
- (2021) Laura Boekel et al. Lancet Rheumatology
- Anti-SARS-CoV-2 mRNA vaccine in patients with rheumatoid arthritis
- (2021) Andrea Rubbert-Roth et al. Lancet Rheumatology
- Adverse events after first COVID-19 vaccination in patients with autoimmune diseases
- (2021) Laura Boekel et al. Lancet Rheumatology
- BNT162b2 vaccine-induced humoral and cellular responses against SARS-CoV-2 variants in systemic lupus erythematosus
- (2021) Quentin Moyon et al. ANNALS OF THE RHEUMATIC DISEASES
- Two-dose COVID-19 vaccination and possible arthritis flare among patients with rheumatoid arthritis in Hong Kong
- (2021) Xue Li et al. ANNALS OF THE RHEUMATIC DISEASES
- Immunogenicity of the COVID-19 mRNA vaccine in adolescents with juvenile idiopathic arthritis on treatment with TNF inhibitors
- (2021) Dimitra Dimopoulou et al. ANNALS OF THE RHEUMATIC DISEASES
- Better outcomes of COVID-19 in vaccinated compared to unvaccinated patients with systemic rheumatic diseases
- (2021) Charalampos Papagoras et al. ANNALS OF THE RHEUMATIC DISEASES
- Evaluation of antibody response to BNT162b2 mRNA COVID-19 vaccine in patients affected by immune-mediated inflammatory diseases up to 5 months after vaccination
- (2021) Davide Firinu et al. CLINICAL AND EXPERIMENTAL MEDICINE
- Side effects and flares risk after SARS-CoV-2 vaccination in patients with systemic lupus erythematosus
- (2021) Ernesto Zavala-Flores et al. CLINICAL RHEUMATOLOGY
- Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients’ subgroups
- (2021) Clodoveo Ferri et al. JOURNAL OF AUTOIMMUNITY
- A prospective multicenter study assessing humoral immunogenicity and safety of the mRNA SARS-CoV-2 vaccines in Greek patients with systemic autoimmune and autoinflammatory rheumatic diseases
- (2021) Athanasios G. Tzioufas et al. JOURNAL OF AUTOIMMUNITY
- Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial
- (2021) Rajeka Lazarus et al. LANCET
- Immunogenicity and safety of mRNA COVID-19 vaccines in people with multiple sclerosis treated with different disease-modifying therapies
- (2021) Fioravante Capone et al. Neurotherapeutics
- Systemic autoimmune myopathies: a prospective phase 4 controlled trial of an inactivated virus vaccine against SARS-CoV-2
- (2021) Samuel K Shinjo et al. RHEUMATOLOGY
- Adverse events of six COVID-19 vaccines in patients with autoimmune rheumatic diseases: a cross-sectional study
- (2021) Jorge Antonio Esquivel-Valerio et al. RHEUMATOLOGY INTERNATIONAL
- COVID-19 vaccine safety and nocebo-prone associated hesitancy in patients with systemic rheumatic diseases: a cross-sectional study
- (2021) George E. Fragoulis et al. RHEUMATOLOGY INTERNATIONAL
- Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults — Nine States, January–September 2021
- (2021) Peter J. Embi et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Safety and tolerability of mRNA COVID-19 vaccines in people with antiphospholipid antibodies
- (2021) Savino Sciascia et al. Lancet Rheumatology
- Efficacy and tolerability of a third dose of an mRNA anti-SARS-CoV-2 vaccine in patients with rheumatoid arthritis with absent or minimal serological response to two previous doses
- (2021) Kristin Schmiedeberg et al. Lancet Rheumatology
- Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2020) Feng-Cai Zhu et al. LANCET
- Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
- (2020) Pedro M Folegatti et al. LANCET
- Phase 1/2 study of COVID-19 RNA vaccine BNT162b1 in adults
- (2020) Mark J. Mulligan et al. NATURE
- Factors associated with COVID-19-related death using OpenSAFELY
- (2020) Elizabeth J. Williamson et al. NATURE
- An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
- (2020) Lisa A. Jackson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion
- (2020) David Simon et al. Nature Communications
- Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
- (2020) Edward E. Walsh et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
- (2020) Evan J. Anderson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses
- (2020) Rinke Bos et al. npj Vaccines
- 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases
- (2019) Victoria Furer et al. ANNALS OF THE RHEUMATIC DISEASES
- Effect of Methotrexate, Anti-Tumor Necrosis Factor α, and Rituximab on the Immune Response to Influenza and Pneumococcal Vaccines in Patients With Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
- (2013) Charlotte Hua et al. ARTHRITIS CARE & RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now